Literature DB >> 15810089

Relationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers.

Jing-Fang Gao1, Gunnar Arbman, Tabasum Imran Wadhra, Hong Zhang, Xiao-Feng Sun.   

Abstract

AIM: The relationships between microsatellite instability (MSI) and survival in colorectal cancer patients are not consistent. The favorable survival of patient with MSI has been suggested to be related to pronounced inflammatory infiltration; however, the reason for non-association of MSI with survival is unclear. Our aims were to investigate the associations of inflammatory infiltration and tumor necrosis (TN) with microsatellite status and clinicopathological factors in colorectal cancer patients in whom MSI was not related to survival.
METHODS: Three hundred and one colorectal adenocarcinomas were evaluated for inflammatory infiltration and 300 for TN under light microscope.
RESULTS: Low infiltration at invasive margin (chi2 = 3.94, P = 0.047) and in whole tumor stroma (chi2 = 3.89, P = 0.049) was associated with MSI, but TN was not (chi2=0.10, P = 0.75). Low infiltration was related to advanced stage (chi2 = 8.67, P = 0.03), poorer differentiation (chi2 = 8.84, P = 0.03), DNA non-diploid (chi2 = 10.04, P = 0.002), higher S-phase fraction (chi2 = 11.30, P = 0.004), positive p53 expression (chi2 = 7.94, P = 0.01), and worse survival (P = 0.03 for both univariate and multivariate analyses). Abundant TN was related to advanced stage (chi2 = 17.74, P = 0.001) and worse survival (P = 0.02 for univariate, and P = 0.05 for multivariate analysis).
CONCLUSION: The result that high inflammatory infiltration was not related to MSI might help explain the non-association of MSI with survival in colorectal cancer patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15810089      PMCID: PMC4305792          DOI: 10.3748/wjg.v11.i14.2179

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Histopathological identification of colon cancer with microsatellite instability.

Authors:  J Alexander; T Watanabe; T T Wu; A Rashid; S Li; S R Hamilton
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.

Authors:  K C Halling; A J French; S K McDonnell; L J Burgart; D J Schaid; B J Peterson; L Moon-Tasson; M R Mahoney; D J Sargent; M J O'Connell; T E Witzig; G H Farr; R M Goldberg; S N Thibodeau
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

3.  Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability.

Authors:  R Gafà; I Maestri; M Matteuzzi; A Santini; S Ferretti; L Cavazzini; G Lanza
Journal:  Cancer       Date:  2000-11-15       Impact factor: 6.860

4.  Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability.

Authors:  Joel K Greenson; Joseph D Bonner; Ofer Ben-Yzhak; Hector I Cohen; Ines Miselevich; Murray B Resnick; Philippe Trougouboff; Lynn D Tomsho; Evelyn Kim; Marcelo Low; Ronit Almog; Gad Rennert; Stephen B Gruber
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

Review 5.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

6.  The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.

Authors:  R J Barth; B J Camp; T A Martuscello; B J Dain; V A Memoli
Journal:  Cancer       Date:  1996-09-15       Impact factor: 6.860

7.  Clinicopathological significance of microsatellite instability and mutated RIZ in colorectal cancer.

Authors:  A Emterling; A Wallin; G Arbman; X-F Sun
Journal:  Ann Oncol       Date:  2004-02       Impact factor: 32.976

8.  Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer.

Authors:  Cathy Wang; Marius van Rijnsoever; Fabienne Grieu; Sean Bydder; Hsny Elsaleh; David Joseph; Jennet Harvey; Barry Iacopetta
Journal:  Oncology       Date:  2003       Impact factor: 2.935

9.  Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.

Authors:  X F Sun; J M Carstensen; H Zhang; O Stål; S Wingren; T Hatschek; B Nordenskjöld
Journal:  Lancet       Date:  1992-12-05       Impact factor: 79.321

10.  Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.

Authors:  M Colombino; A Cossu; A Manca; M F Dedola; M Giordano; F Scintu; A Curci; A Avallone; G Comella; M Amoruso; A Margari; G M Bonomo; M Castriota; F Tanda; G Palmieri
Journal:  Ann Oncol       Date:  2002-09       Impact factor: 32.976

View more
  8 in total

1.  Histopathologic risk stratification of stage IIB colorectal cancer.

Authors:  Koji Komori; Takashi Kinoshita; Taihei Oshiro; Seiji Ito; Tetsuya Abe; Yoshiki Senda; Kazunari Misawa; Yuichi Ito; Norihisa Uemura; Seiji Natsume; Jiro Kawakami; Akira Ouchi; Masayuki Tsutsuyama; Takahiro Hosoi; Itaru Shigeyoshi; Tomoyuk Akazawa; Daisuke Hayashi; Hideharu Tanaka; Yasuhiro Shimizu
Journal:  Surg Today       Date:  2016-12-30       Impact factor: 2.549

Review 2.  Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.

Authors:  Xiao-Feng Sun; Hong Zhang
Journal:  Mol Cancer       Date:  2006-10-06       Impact factor: 27.401

Review 3.  Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.

Authors:  Z Mei; Y Liu; C Liu; A Cui; Z Liang; G Wang; H Peng; L Cui; C Li
Journal:  Br J Cancer       Date:  2014-02-06       Impact factor: 7.640

4.  Prognostic Heterogeneity of MRE11 Based on the Location of Primary Colorectal Cancer Is Caused by Activation of Different Immune Signals.

Authors:  Chuan-Wen Fan; Maria Kopsida; You-Bin Liu; Hong Zhang; Jing-Fang Gao; Gunnar Arbman; Si-Yu-Wei Cao; Yuan Li; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

5.  Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from routine histology images: a retrospective study.

Authors:  Mohsin Bilal; Shan E Ahmed Raza; Ayesha Azam; Simon Graham; Mohammad Ilyas; Ian A Cree; David Snead; Fayyaz Minhas; Nasir M Rajpoot
Journal:  Lancet Digit Health       Date:  2021-10-19

6.  Neutrophil infiltration combined with necrosis in the primary tumor is a useful prognostic indicator for three-year disease-free survival time in patients with colorectal cancer.

Authors:  Katarzyna Jakubowska; Mariusz Koda; Małgorzata Grudzińska; Wojciech Kisielewski; Karolina Lomperta; Waldemar Famulski
Journal:  Oncol Lett       Date:  2022-05-06       Impact factor: 2.967

7.  Buffalo Milk Whey Activates Necroptosis and Apoptosis in a Xenograft Model of Colorectal Cancer.

Authors:  Nunzio Antonio Cacciola; Angela Salzano; Nunzia D'Onofrio; Tommaso Venneri; Paola De Cicco; Francesco Vinale; Orsolina Petillo; Manuela Martano; Paola Maiolino; Gianluca Neglia; Ciro Campanile; Lorella Severino; Carmine Merola; Francesca Borrelli; Maria Luisa Balestrieri; Giuseppe Campanile
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

8.  Clinical impact and network of determinants of tumour necrosis in colorectal cancer.

Authors:  Sara A Väyrynen; Juha P Väyrynen; Kai Klintrup; Jyrki Mäkelä; Tuomo J Karttunen; Anne Tuomisto; Markus J Mäkinen
Journal:  Br J Cancer       Date:  2016-05-19       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.